Skip to main content

previous disabled Page of 2
and
  1. No Access

    Chapter

    Mammary-Derived Growth Inhibitor (MDGI)

    In contrast to the steadily increasing number of growth factors capable of stimulating cells to synthesize DNA and to divide, very little is known about their potential antagonists, which are supposed to contr...

    Richard Grosse, Frank-D. Böhmer, Bert Binas in Genes, Oncogenes, and Hormones (1992)

  2. No Access

    Article

    Expression of a binding protein for FGF is associated with epithelial development and skin carcinogenesis

    Fibroblast growth factors (FGF)-1 and -2 are found in most embryonic and adult normal and tumor tissues, where they are immobilized in the extracellular matrix (EM). Mobilization of these FGFs is part of a tig...

    Andreas Kurtz, Huey-Lin Wang, Nadine Darwiche, Violaine Harris, Anton Wellstein in Oncogene (1997)

  3. No Access

    Article

    Breast cancer growth inhibition by delivery of the MDGI-derived peptide P108

    Mammary derived growth inhibitor (MDGI) is a member of the family of cytoplasmic fatty acid binding proteins (FABPs), which bind hydrophobic ligands such as fatty acids, retinoids, eicosanoids and prostaglandi...

    Huey-Ling Wang, Andreas Kurtz in Oncogene (2000)

  4. No Access

    Article

    The angiogenic factor midkine is aberrantly expressed in NF1-deficient Schwann cells and is a mitogen for neurofibroma-derived cells

    Loss of the tumor suppressor gene NF1 in neurofibromatosis type 1 (NF1) contributes to the development of a variety of tumors, including malignant peripheral nerve sheath tumors (MPNST) and benign neurofibromas. ...

    George A Mashour, Nancy Ratner, Galam A Khan, Huey-Ling Wang, Robert L Martuza in Oncogene (2001)

  5. Article

    Open Access

    Sulindac derivatives inhibit cell growth and induce apoptosis in primary cells from malignant peripheral nerve sheath tumors of NF1-patients

    Malignant peripheral nerve sheath tumors (MPNSTs) are neoplasms leading to death in most cases. Patients with Neurofibromatosis type 1 have an increased risk of develo** this malignancy. The metabolites of t...

    Silke Frahm, Andreas Kurtz, Lan Kluwe, Faris Farassati in Cancer Cell International (2004)

  6. No Access

    Article

    Differential modulation of malignant peripheral nerve sheath tumor growth by omega-3 and omega-6 fatty acids

    Neurofibromatosis type 1 (NF1) is a common genetic disorder of the nervous system resulting in neurofibromas and malignant peripheral nerve sheath tumors (MPNST). In this study, we report the modulation of mur...

    George A Mashour, Stephanie N Drissel, Silke Frahm, Faris Farassati in Oncogene (2005)

  7. No Access

    Article

    First evaluation of the European hESCreg

    Joeri Borstlap, Glyn Stacey, Andreas Kurtz, Anja Elstner in Nature Biotechnology (2008)

  8. Article

    Open Access

    Histone deacetylase controls adult stem cell aging by balancing the expression of polycomb genes and jumonji domain containing 3

    Aging is linked to loss of the self-renewal capacity of adult stem cells. Here, we observed that human multipotent stem cells (MSCs) underwent cellular senescence in vitro. Decreased expression of histone deac...

    Ji-Won Jung, Seunghee Lee, Min-Soo Seo in Cellular and Molecular Life Sciences (2010)

  9. No Access

    Article

    Imatinib mesylate (Glivec) inhibits Schwann cell viability and reduces the size of human plexiform neurofibroma in a xenograft model

    Plexiform neurofibromas (PNF), one of the major features of neurofibromatosis type 1 (NF1), are characterized by complex cellular composition and mostly slow but variable growth patterns. In this study, we exa...

    Maria Demestre, Jan Herzberg, Nikola Holtkamp, Christian Hagel in Journal of Neuro-Oncology (2010)

  10. No Access

    Article

    Isolation and characterization of fenamiphos degrading bacteria

    The biological factors responsible for the microbial breakdown of the organophosphorus nematicide fenamiphos were investigated. Microorganisms responsible for the enhanced degradation of fenamiphos were isolat...

    J. Alfonso Cabrera, Andreas Kurtz, Richard A. Sikora, Alexander Schouten in Biodegradation (2010)

  11. Article

    Open Access

    Identification of diagnostic serum protein profiles of glioblastoma patients

    Diagnosis of a glioblastoma (GBM) is triggered by the onset of symptoms and is based on cerebral imaging and histological examination. Serum-based biomarkers may support detection of GBM. Here, we explored ser...

    Anja Elstner, Florian Stockhammer, Trong-Nghia Nguyen-Dobinsky in Journal of Neuro-Oncology (2011)

  12. No Access

    Chapter

    Status and Impact of Research on Human Pluripotent Stem Cells: Cell Lines and Their Use in Published Research

    Research on human pluripotent stem cells is rapidly progressing. In the present chapter the current state of research on human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs) is ...

    Peter Löser, Anke Guhr, Sabine Kobold in Stem Cells and Cancer Stem Cells, Volume 2 (2012)

  13. Article

    Open Access

    Scope and Impact of International Research in Human Pluripotent Stem Cells

    In a recent study published in this journal it was claimed that the rate of publications from US-based authors in the human embryonic stem cell (hESC) research field was slowing or even declining from 2008 to ...

    Peter Löser, Sabine Kobold, Anke Guhr, Franz-Josef Müller in Stem Cell Reviews and Reports (2012)

  14. Article

    Open Access

    Serum biomarkers for neurofibromatosis type 1 and early detection of malignant peripheral nerve-sheath tumors

    Neurofibromatosis type 1 (NF1) is a hereditary tumor syndrome characterized by the development of benign nerve-sheath tumors, which transform to malignant peripheral nerve-sheath tumors (MPNST) in about 8 to 1...

    Su-** Park, Birgit Sawitzki, Lan Kluwe, Victor F Mautner, Nikola Holtkamp in BMC Medicine (2013)

  15. Article

    Open Access

    CELDA - an ontology for the comprehensive representation of cells in complex systems

    The need for detailed description and modeling of cells drives the continuous generation of large and diverse datasets. Unfortunately, there exists no systematic and comprehensive way to organize these dataset...

    Stefanie Seltmann, Harald Stachelscheid, Alexander Damaschun in BMC Bioinformatics (2013)

  16. Article

    Open Access

    Impact of heart failure on the behavior of human neonatal stem cells in vitro

    Clinical cardiac cell therapy using autologous somatic stem cells is restricted by age and disease-associated impairment of stem cell function. Juvenile cells possibly represent a more potent alternative, but ...

    Kristin Klose, Rajika Roy, Andreja Brodarac in Journal of Translational Medicine (2013)

  17. Article

    Open Access

    Using ontologies to study cell transitions

    Understanding, modelling and influencing the transition between different states of cells, be it reprogramming of somatic cells to pluripotency or trans-differentiation between cells, is a hot topic in current...

    Georg Fuellen, Ludger Jansen, Ulf Leser, Andreas Kurtz in Journal of Biomedical Semantics (2013)

  18. No Access

    Article

    Effects of pigment epithelium derived factor (PEDF) on malignant peripheral nerve sheath tumours (MPNSTs)

    Neurofibromatosis type 1 (NF1) is an inherited genetic disease affecting 1 in 3,500 individuals. A prominent feature of NF1 is the formation of benign tumours of the peripheral nerve sheath (neurofibromas). Ho...

    Maria Demestre, Menderes Yusuf Terzi, Victor Mautner in Journal of Neuro-Oncology (2013)

  19. Article

    Open Access

    Comparative computational analysis of pluripotency in human and mouse stem cells

    Pluripotent cells can be subdivided into two distinct states, the naïve and the primed state, the latter being further advanced on the path of differentiation. There are substantial differences in the regulati...

    Mathias Ernst, Raed Abu Dawud, Andreas Kurtz, Gunnar Schotta in Scientific Reports (2015)

  20. No Access

    Article

    Human adipose-Derived Mesenchymal Stem Cells Improve Motor Functions and are Neuroprotective in the 6-Hydroxydopamine-Rat Model for Parkinson’s Disease when Cultured in Monolayer Cultures but Suppress Hippocampal Neurogenesis and Hippocampal Memory Function when Cultured in Spheroids

    Adult human adipose-derived mesenchymal stem cells (MSC) have been reported to induce neuroprotective effects in models for Parkinson´s disease (PD). However, these effects strongly depend on the most optimal ...

    Jürgen Berg, Manfred Roch, Jennifer Altschüler in Stem Cell Reviews and Reports (2015)

previous disabled Page of 2